Market news

Investors need to pay close attention to CC stock based on the movements in the options market lately.

On September 9, 2026, Chemours, DuPont, and Corteva reached a settlement with North Carolina and 11 nearby local entities, agreeing to pay US$455 million over 15 years to resolve PFAS-related claims tied to Chemours’ Fayetteville Works facility and other contamination issues. The agreement not only clears a significant portion of Chemours’ legacy PFAS exposure but also introduces a shared, net-present-value framework under the companies’ existing US$4.00 billion cost-sharing cap, potentially...

On August 4, The Chemours Company (NYSE:CC) reported second-quarter results that read like two different companies fused. Net sales barely moved, adjusted profit shrank, and yet cash generation surged, and the loss on the bottom line narrowed sharply. For a stock trading under $40, that split personality is exactly what makes this quarter worth a […]

Detailed price information for CRH Plc ADR (CRH-N) from The Globe and Mail including charting and trades.

The Chemours Company (NYSE:CC) shares traded higher Thursday after the company, DuPont, and Corteva reached a $455 million settlement resolving PFAS-related litigation in North Carolina. The gain came despite broader weakness, with the S&P 500 down 0.43% and the Materials sector falling 1.24%. Chemours’ Share Covered By Existing Accruals Chemours, DuPont de Nemours, Inc. (NYSE:DD), and Corteva, Inc. (NYSE:CTVA) reached a $455 million settlement with North Carolina and 11 local entities over PFAS

Chemours (NYSE:CC) shares rose 6% on Thursday after the company announced a settlement with the State of North Carolina and 11 local entities covering PFAS-related claims. The agreement resolves litigation concerning PFAS and other historical discharges from the Fayetteville Works facility, as well as claims involving alleged PFAS contamination unrelated to the site, including the use of aqueous film forming foam.

DuPont, Chemours & Corteva to pay $455M PFAS settlement in North Carolina.

Sept 10 (Reuters) - Chemours, DuPont and Corteva on Thursday reached a $455 million settlement with North Carolina and 11 local entities over PFAS contamination claims tied to Chemours' Fayetteville

The Chemours Company (NYSE: CC) (the "Company") today announced that, along with DuPont de Nemours, Inc. ("Dupont") and Corteva, Inc. ("Corteva"), it has entered into a settlement (the "Settlement") with the State of North Carolina (the "State") and 11 local entities* in the vicinity of the Company's Fayetteville Works facility that were excluded from the U.S. Public Water System Class Settlement approved in 2024.

DuPont (NYSE: DD) today announced that, together with The Chemours Company ("Chemours"), and Corteva Inc. and its subsidiary EIDP Inc. (formerly known as E. I. du Pont de Nemours and Company and together with its parent, Corteva Inc., referred to as "Corteva"), it has entered into a settlement (the "Settlement") with the State of North Carolina and 11 local entities* in the vicinity of the Company's Fayetteville Works facility that were excluded from the U.S. Public Water System Class Settlement

On August 10, Chemours (NYSE:CC) launched two new refrigerants, Opteon ZE and Opteon 515B, built specifically for stationary chillers that cool data centers, commercial buildings, and other facilities that cannot afford downtime. The announcement lands as data center operators everywhere are scrambling to keep pace with the heat that AI workloads generate, and Chemours is […]

Detailed price information for Solstice Advanced Materials Inc (SOLS-Q) from The Globe and Mail including charting and trades.

CC expands its low-GWP Opteon refrigerant portfolio to meet rising cooling needs from AI-driven data centers and support decarbonization goals.

Detailed price information for West Fraser Timber L (WFG-N) from The Globe and Mail including charting and trades.

Chemours stock has delivered a steep 48.2% decline over the past three years, yet its current valuation checks lean cheap. This sets up a contrast between past shareholder experience and what today’s price suggests. Recent headlines around refrigerant demand and new product launches add another layer for investors trying to judge whether the current level offers enough compensation for those risks. The share price is down 48.2% over three years, which signals that investors have been pricing...

Detailed price information for Chemours Company (CC-N) from The Globe and Mail including charting and trades.

CC's Q2 loss narrows, but lower volumes and sales weigh on results as it outlines a cautious Q3 outlook.

Chemours' (CC) recent financial results have cast less certainty on its medium-term growth, with its

The Chemours Company (Chemours) (NYSE: CC), a global chemistry company, today announced the launch of Opteon™ ZE (R-1234ze(E)) and Opteon™ 515B (R-515B) for stationary chiller applications. The products further expand the industry-leading Opteon™ portfolio and provide customers with additional low-global warming potential (GWP) refrigerant options for large-scale cooling applications, including rapidly growing AI and data center infrastructure.

Chemours reported a lackluster second quarter, given the enthusiasm for its AI business heading in.

Chemours (NYSE:CC) said its second-quarter results reflected pricing gains, operational improvements and continued execution under its Pathway to Thrive strategy, while softer residential air-conditioning aftermarket demand weighed on sales in its Thermal & Specialized Solutions business. Presi

Chemours reported a lackluster second quarter, given the enthusiasm for its AI business heading in.

Chemours beats EBITDA expectations on pricing strength and APM growth, but cuts full-year guidance amid TSS aftermarket destocking and soft residential demand.

Moby summary of The Chemours Company's Q2 2026 earnings call

The headline numbers for Chemours (CC) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Chemours (CC) delivered earnings and revenue surprises of -2.33% and -4.97%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Chemours Co (CC) posted Q2 adjusted earnings late Tuesday of $0.42 per diluted share, down from $0.6

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Chemours (CC) Q2 results: shares drop on weak Q3 outlook as refrigerant demand cools, offset by data center/semiconductor strength and better cash flow—read...